Regulation And Legal
Dr Lalchandani Labs: No Price-Sensitive Information Pending
Company responds to BSE query on share price movement under SEBI LODR Regulation 30.
Confirms no pending price-sensitive information exists that could impact share price.
Attributes recent share price
